When it comes to the Johnson & Johnson Covid-19 vaccine, remember what Guns N’ Roses said: “All we need is just a little patience.”
Last Thursday, Johnson & Johnson (J&J) announced that they had submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its Janssen Covid-19 vaccine candidate. FDA officials will then review the submitted data, compile a report, and submit the report to an independent vaccine advisory committee. The committee will then meet on February 26 and make their recommendation, which means that the FDA could decide on a EUA by the end of February.
That would be a 22-day turnaround, which…